Zdrowie i gospodarka · 20/07/2000
FDA Publishes Draft Revised Guidance on Impurities in New Drug Substances
The FDA is releasing a revised guidance on impurities in new drug substances, clarifying and updating previous guidance, in collaboration with the International Conference on Harmonisation, to help applicants register their drugs
Source: Federal Register — Food and Drug AdministrationOpen original release →